Tech Company Financing Transactions

Matrix Genetics Funding Round

Matrix Genetics, based in Seattle, secured investment capital from Avista.

Transaction Overview

Company Name
Announced On
8/30/2012
Transaction Type
Venture Equity
Amount
Unknown
Round
Undisclosed
Investors
Proceeds Purpose
The amount of the investment isn't being disclosed, but it's enough for Matrix to spin out of its parent company, Targeted Growth, and to find new labs in South Lake Union with room for about 15 employees.

Company Information

Company Status
Private & Independent
Industry
Clean Tech
Mailing Address
1600 Fairview Ave. E 300
Seattle, WA 98102
USA
Email Address
Not Recorded
Overview
Matrix Genetics is a biotechnology company focused on producing renewable fuel and specialty chemicals derived from cyanobacteria (blue-green algae).
Profile
Matrix Genetics LinkedIn Company Profile
Social Media
Matrix Genetics Company Twitter Account
Company News
Matrix Genetics News
Facebook
Matrix Genetics on Facebook
YouTube
Matrix Genetics on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Margaret McCormick
  Margaret McCormick LinkedIn Profile  Margaret McCormick Twitter Account  Margaret McCormick News  Margaret McCormick on Facebook
Chief Scientific Officer
James Roberts
  James Roberts LinkedIn Profile  James Roberts Twitter Account  James Roberts News  James Roberts on Facebook


 

 

Browse more venture capital transactions:

Prev: 8/30/2012: Celator Pharmaceuticals venture capital transaction
Next: 8/30/2012: Intarcia Therapeutics venture capital transaction

 

Share this article

 


Where The Data Comes From

We do our best to report on every notable VC transaction. VC investment data records on this site are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary